Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Coronary Artery Disease: HELP
Articles by Josepa Mauri Ferre
Based on 5 articles published since 2008
||||

Between 2008 and 2019, Josepa Mauri-Ferré wrote the following 5 articles about Coronary Artery Disease.
 
+ Citations + Abstracts
1 Guideline Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology. 2013

Hamon, Martial / Pristipino, Christian / Di Mario, Carlo / Nolan, James / Ludwig, Josef / Tubaro, Marco / Sabate, Manel / Mauri-Ferré, Josepa / Huber, Kurt / Niemelä, Kari / Haude, Michael / Wijns, William / Dudek, Dariusz / Fajadet, Jean / Kiemeneij, Ferdinand / Anonymous3350748 / Anonymous3360748 / Anonymous3370748. ·Recherche Clinique, Bureau 364, Centre Hospitalier Universitaire de Caen, Avenue Côte de Nacre, 14033 Caen, Normandie, France. hamon-m@chu-caen.fr ·EuroIntervention · Pubmed #23354100.

ABSTRACT: Radial access use has been growing steadily but, despite encouraging results, still varies greatly among operators, hospitals, countries and continents. Twenty years from its introduction, it was felt that the time had come to develop a common evidence-based view on the technical, clinical and organisational implications of using the radial approach for coronary angiography and interventions. The European Association of Percutaneous Cardiovascular Interventions (EAPCI) has, therefore, appointed a core group of European and non-European experts, including pioneers of radial angioplasty and operators with different practices in vascular access supported by experts nominated by the Working Groups on Acute Cardiac Care and Thrombosis of the European Society of Cardiology (ESC). Their goal was to define the role of the radial approach in modern interventional practice and give advice on technique, training needs, and optimal clinical indications.

2 Article Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. 2018

Varenne, Olivier / Cook, Stéphane / Sideris, Georgios / Kedev, Sasko / Cuisset, Thomas / Carrié, Didier / Hovasse, Thomas / Garot, Philippe / El Mahmoud, Rami / Spaulding, Christian / Helft, Gérard / Diaz Fernandez, José F / Brugaletta, Salvatore / Pinar-Bermudez, Eduardo / Mauri Ferre, Josepa / Commeau, Philippe / Teiger, Emmanuel / Bogaerts, Kris / Sabate, Manel / Morice, Marie-Claude / Sinnaeve, Peter R / Anonymous8010925. ·Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; Cardiology Department, Université Paris Descartes, Sorbonne Paris-Cité, Paris, France. Electronic address: olivier.varenne@aphp.fr. · Cardiology Department, University and Hospital Fribourg, Fribourg, Switzerland. · Service de Cardiologie-Institut national de la santé et de la recherche médicale U942, Hôpital Lariboisiere, Assistance Publique - Hôpitaux de Paris, Université Paris Diderot, Paris, France. · Cardiology Department, University St Cyril and Methodius, Skopje, Macedonia. · Département de Cardiologie, Centre hospitalier universitaire Timone, Marseille, France. · Service de Cardiologie, Centre hospitalier universitaire Toulouse Rangueil, Université Paul Sabatier, Toulouse, France. · Institut Cardiovasculaire Paris-Sud, Ramsay Générale de Santé, Massy and Quincy, France. · Hôpital Ambroise Paré Assistance Publique-Hôpitaux de Paris, Université Versailles-Saint Quentin en Yvelines, Versailles, France. · Service de Cardiologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris Descartes University and Sudden Death Expert Center, Institut national de la santé et de la recherche médicale U990, Paris, France. · Institut de Cardiologie, Hôpital Pitié-Salpétrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie et Institut hospitalo-universitaire, Institute of Cardiometabolism and Nutrition, Hôpital Pitié-Salpétrière, Paris, France. · Juan Ramón Jiménez University Hospital, Huelva, Spain. · Cardiovascular Institute, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Hospital Universitario Virgen de la Arrixaca, Murcia, Spain. · Hospital Universitari Germans Trias i Pujol, Badalona, Spain. · Département de Cardiologie Interventionnelle, Polyclinique Les Fleurs, Ollioules, France. · Service de Cardiologie, Hôpital Henri Mondor Assistance Publique-Hôpitaux de Paris, Université Paris Est Créteil, Créteil, France. · Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BioStat), Department of Public Health and Primary Care, Katholieke Universiteit Leuven, Leuven, Belgium; Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-BioStat), University Hasselt, Hasselt, Belgium. · Interventional Cardiology Unit, Cardiovascular Institute, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Cardiovascular European Research Center, Massy, France. · Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium. ·Lancet · Pubmed #29102362.

ABSTRACT: BACKGROUND: Elderly patients regularly receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of double antiplatelet therapy (DAPT). The aim of this study was to compare outcomes between these two types of stents with a short duration of DAPT in such patients. METHODS: In this randomised single-blind trial, we recruited patients from 44 centres in nine countries. Patients were eligible if they were aged 75 years or older; had stable angina, silent ischaemia, or an acute coronary syndrome; and had at least one coronary artery with a stenosis of at least 70% (≥50% for the left main stem) deemed eligible for percutaneous coronary intervention (PCI). Exclusion criteria were indication for myocardial revascularisation by coronary artery bypass grafting; inability to tolerate, obtain, or comply with DAPT; requirement for additional surgery; non-cardiac comorbidities with a life expectancy of less than 1 year; previous haemorrhagic stroke; allergy to aspirin or P2Y FINDINGS: Between May 21, 2014, and April 16, 2016, we randomly assigned 1200 patients (596 [50%] to the DES group and 604 [50%] to the BMS group). The primary endpoint occurred in 68 (12%) patients in the DES group and 98 (16%) in the BMS group (relative risk [RR] 0·71 [95% CI 0·52-0·94]; p=0·02). Bleeding complications (26 [5%] in the DES group vs 29 [5%] in the BMS group; RR 0·90 [0·51-1·54]; p=0·68) and stent thrombosis (three [1%] vs eight [1%]; RR 0·38 [0·00-1·48]; p=0·13) at 1 year were infrequent in both groups. INTERPRETATION: Among elderly patients who have PCI, a DES and a short duration of DAPT are better than BMS and a similar duration of DAPT with respect to the occurrence of all-cause mortality, myocardial infarction, stroke, and ischaemia-driven target lesion revascularisation. A strategy of combination of a DES to reduce the risk of subsequent repeat revascularisations with a short BMS-like DAPT regimen to reduce the risk of bleeding event is an attractive option for elderly patients who have PCI. FUNDING: Boston Scientific.

3 Article Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. 2014

de la Torre Hernandez, Jose M / Baz Alonso, José A / Gómez Hospital, Joan A / Alfonso Manterola, Fernando / Garcia Camarero, Tamara / Gimeno de Carlos, Federico / Roura Ferrer, Gerard / Recalde, Angel Sanchez / Martínez-Luengas, Iñigo Lozano / Gomez Lara, Josep / Hernandez Hernandez, Felipe / Pérez-Vizcayno, María J / Cequier Fillat, Angel / Perez de Prado, Armando / Gonzalez-Trevilla, Agustín Albarrán / Jimenez Navarro, Manuel F / Mauri Ferre, Josepa / Fernandez Diaz, Jose A / Pinar Bermudez, Eduardo / Zueco Gil, Javier / Anonymous4770788. ·Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital Marques de Valdecilla, Santander, Spain. Electronic address: he1thj@humv.es. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital Meixoeiro, Vigo, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital Bellvitge, Barcelona, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital Clinico San Carlos, Madrid, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital Marques de Valdecilla, Santander, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital de Valladolid, Valladolid, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital La Paz, Madrid, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital Central de Asturias, Oviedo, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital 12 de Octubre, Madrid, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital de Leon, Leon, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital Virgen de la Victoria, Malaga, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital Germans Trias i Pujol, Badalona, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital Puerta de Hierro, Madrid, Spain. · Unidad de Cardiología Intervencionista, Servicio de Cardiología, Hospital Virgen de la Arrixaca, Murcia, Spain. ·JACC Cardiovasc Interv · Pubmed #24650399.

ABSTRACT: OBJECTIVES: This study sought to investigate the clinical impact of the use of intravascular ultrasound (IVUS) during revascularization of patients with left main coronary artery (LM) disease with drug-eluting stents (DES). BACKGROUND: Whether the use of IVUS during the procedure adds a clinical benefit remains unclear. There is only 1 previous observational study, with relevant limitations, supporting the value of this strategy. METHODS: We performed a patient-level pooled analysis of 4 registries of patients with LM disease treated with DES in Spain. A propensity score-matching method was used to obtain matched pairs of patients with and without IVUS guidance. RESULTS: A total of 1,670 patients were included, and 505 patients (30.2%) underwent DES implantation under IVUS guidance (IVUS group). By means of the matching method, 505 patients without the use of IVUS during revascularization were selected (no-IVUS group). Survival free of cardiac death, myocardial infarction, and target lesion revascularization at 3 years was 88.7% in the IVUS group and 83.6% in the no-IVUS group (p = 0.04) for the overall population, and 90% and 80.7%, respectively (p = 0.03), for the subgroups with distal LM lesions. The incidence of definite and probable thrombosis was significantly lower in the IVUS group (0.6% vs. 2.2%; p = 0.04). Finally, IVUS-guided revascularization was identified as an independent predictor for major adverse events in the overall population (hazard ratio: 0.70, 95% confidence interval: 0.52 to 0.99; p = 0.04) and in the subgroup with distal lesions (hazard ratio: 0.54, 95% confidence interval: 0.34 to 0.90; p = 0.02). CONCLUSIONS: The results of this pooled analysis show an association of IVUS guidance during percutaneous coronary intervention with better outcomes in patients with LM disease undergoing revascularization with DES.

4 Article HoliMAb: a holistic approach for Media-Adventitia border detection in intravascular ultrasound. 2012

Ciompi, Francesco / Pujol, Oriol / Gatta, Carlo / Alberti, Marina / Balocco, Simone / Carrillo, Xavier / Mauri-Ferre, Josepa / Radeva, Petia. ·Department of Applied Mathematics and Analysis, University of Barcelona, Barcelona, Spain. fciompi@maia.ub.es ·Med Image Anal · Pubmed #22854037.

ABSTRACT: We present a fully automatic methodology for the detection of the Media-Adventitia border (MAb) in human coronary artery in Intravascular Ultrasound (IVUS) images. A robust border detection is achieved by means of a holistic interpretation of the detection problem where the target object, i.e. the media layer, is considered as part of the whole vessel in the image and all the relationships between tissues are learnt. A fairly general framework exploiting multi-class tissue characterization as well as contextual information on the morphology and the appearance of the tissues is presented. The methodology is (i) validated through an exhaustive comparison with both Inter-observer variability on two challenging databases and (ii) compared with state-of-the-art methods for the detection of the MAb in IVUS. The obtained averaged values for the mean radial distance and the percentage of area difference are 0.211 mm and 10.1%, respectively. The applicability of the proposed methodology to clinical practice is also discussed.

5 Article Fusing in-vitro and in-vivo intravascular ultrasound data for plaque characterization. 2010

Ciompi, Francesco / Pujol, Oriol / Gatta, Carlo / Rodríguez-Leor, Oriol / Mauri-Ferré, Josepa / Radeva, Petia. ·Department Matemàtica Aplicada i Anàlisi, Universitat de Barcelona, Gran Via de les Corts Catalanes 585, Barcelona, Spain. fciompi@maia.ub.es ·Int J Cardiovasc Imaging · Pubmed #20091123.

ABSTRACT: Accurate detection of in-vivo vulnerable plaque in coronary arteries is still an open problem. Recent studies show that it is highly related to tissue structure and composition. Intravascular Ultrasound (IVUS) is a powerful imaging technique that gives a detailed cross-sectional image of the vessel, allowing to explore arteries morphology. IVUS data validation is usually performed by comparing post-mortem (in-vitro) IVUS data and corresponding histological analysis of the tissue. The main drawback of this method is the few number of available case studies and validated data due to the complex procedure of histological analysis of the tissue. On the other hand, IVUS data from in-vivo cases is easy to obtain but it can not be histologically validated. In this work, we propose to enhance the in-vitro training data set by selectively including examples from in-vivo plaques. For this purpose, a Sequential Floating Forward Selection method is reformulated in the context of plaque characterization. The enhanced classifier performance is validated on in-vitro data set, yielding an overall accuracy of 91.59% in discriminating among fibrotic, lipidic and calcified plaques, while reducing the gap between in-vivo and in-vitro data analysis. Experimental results suggest that the obtained classifier could be properly applied on in-vivo plaque characterization and also demonstrate that the common hypothesis of assuming the difference between in-vivo and in-vitro as negligible is incorrect.